comparemela.com

Latest Breaking News On - Thrombosis - Page 9 : comparemela.com

Daily Aspirin Challenged for Preventing First Strokes

The numbers were small, but "numerically, the bleeding events outweighed any possible prevention of ischemic events," said an ASPREE investigator.

Australia
New-york
United-states
Melbourne
Victoria
Monash
South-australia
Johnj-mcneil
Us-preventive-services-task
Monash-university
Grossman-school-of-medicine

Ticagrelor-acetylsalicylic acid may reduce stroke risk further for obese patients than clopidogrel

1. For obese patients with minor stroke or transient ischemic attacks (TIA), subsequent therapy with ticagrelor-acetylsalicylic acid (ASA) was associated with lower risk of subsequent stroke compared to clopidogrel-ASA. 2. This difference in risk reduction was not observed in nonobese patients. Evidence Rating Level: 1 (Excellent) The treatment of patients with minor ischemic stroke and

Rating-level
High-risk-patients
Acute-nondisabling-cerebrovascular-events
Cardiology
Adapt
Neurology
Stroke
Thrombosis
Chronic-disease
Hematology

2 Minute Medicine Rewind July 17, 2023 | 2 Minute Medicine

Results following implementation of a cardiac surgery ERAS protocol 1. Postoperative enhanced recovery after surgery (ERAS) protocols for cardiac surgeries were found to improve outcomes such as decreasing the length of stay (LOS) and incidences of postoperative infections. 2. There was a significantly reduced 30-day mortality for patients who underwent open aortic surgeries after the

Taiwan
Taiwanese
National-health-insurance-research-database
Rating-level
Standford-hospital
High-risk-patients
Acute-nondisabling-cerebrovascular-events
Health-insurance-research-database
Neurology
Pediatrics
Psychiatry

Risk for Incident VTE Increased in Adults With AD

2 Minute Medicine Rewind May 29, 2023 | 2 Minute Medicine

Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial 1. Rivaroxaban is safe and effective for venous thromboembolism (VTE) prophylaxis post-bariatric surgery. 2. Similar efficacy and safety profiles were observed with 10 mg rivaroxaban daily for either 7 or 28 days. Evidence Rating Level: 1 (Excellent) Individuals

Saudi-arabia
Sri-lanka
Sweden
Minute-medicine-inc
Rating-level
Fugl-meyer-assessment
Upper-limb
Covid-19
Kent
Hematology
Neurology

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.